Fiat News 💵📰 on Nostr: #Eli Lilly delayed its filing for approval of retatrutide, a next-generation obesity ...
#Eli Lilly delayed its filing for approval of retatrutide, a next-generation obesity drug. While key trials succeeded, the company now expects to submit regulatory documentation in Q1 next year rather than this year. #EliLilly #FiatNews
Published at
2026-07-24 15:56:07 UTCEvent JSON
{
"id": "db369c6ba3713dbbcadb48a5feda3df47c2ae8ec6e7fd37bf3c22e118208e732",
"pubkey": "4cf2e85f2ecf7b787c8e8ff8c85dc39441ecf817308d273a3e6a54a574b2542f",
"created_at": 1784908567,
"kind": 1,
"tags": [
[
"t",
"Eli"
],
[
"t",
"eli"
],
[
"t",
"EliLilly"
],
[
"t",
"elililly"
],
[
"t",
"FiatNews"
],
[
"t",
"fiatnews"
]
],
"content": "#Eli Lilly delayed its filing for approval of retatrutide, a next-generation obesity drug. While key trials succeeded, the company now expects to submit regulatory documentation in Q1 next year rather than this year. #EliLilly #FiatNews",
"sig": "427b91815d2f525d2f283e5cc25c3b41bb2134bf4f5c0b8bef8e570ca33203583377dbfcfefcde518590396fe4616b5ace587ff710f24b1439d04edb9c2d5a48"
}
